These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 15618009)
1. KAI1 tetraspanin and metastasis suppressor. Jackson P; Marreiros A; Russell PJ Int J Biochem Cell Biol; 2005 Mar; 37(3):530-4. PubMed ID: 15618009 [TBL] [Abstract][Full Text] [Related]
2. Genomic organization of the human KAI1 metastasis-suppressor gene. Dong JT; Isaacs WB; Barrett JC; Isaacs JT Genomics; 1997 Apr; 41(1):25-32. PubMed ID: 9126478 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131 [TBL] [Abstract][Full Text] [Related]
4. KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells. Marreiros A; Dudgeon K; Dao V; Grimm MO; Czolij R; Crossley M; Jackson P Oncogene; 2005 Jan; 24(4):637-49. PubMed ID: 15580298 [TBL] [Abstract][Full Text] [Related]
5. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer. Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410 [TBL] [Abstract][Full Text] [Related]
6. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity. Zhou B; Liu L; Reddivari M; Zhang XA Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270 [TBL] [Abstract][Full Text] [Related]
7. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Lee JH; Park SR; Chay KO; Seo YW; Kook H; Ahn KY; Kim YJ; Kim KK Cancer Res; 2004 Jun; 64(12):4235-43. PubMed ID: 15205336 [TBL] [Abstract][Full Text] [Related]
8. Loss of KAI1 expression in the progression of colorectal cancer. Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691 [TBL] [Abstract][Full Text] [Related]
9. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma. Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402 [TBL] [Abstract][Full Text] [Related]
10. Is the KAI1 metastasis suppressor gene a cellular target of p53? A review of current evidence. Jackson P; Puisieux A Biochem Biophys Res Commun; 2000 Nov; 278(3):499-502. PubMed ID: 11095940 [No Abstract] [Full Text] [Related]
11. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines. White A; Lamb PW; Barrett JC Oncogene; 1998 Jun; 16(24):3143-9. PubMed ID: 9671393 [TBL] [Abstract][Full Text] [Related]
12. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers. Yu Y; Yang JL; Markovic B; Jackson P; Yardley G; Barrett J; Russell PJ Clin Cancer Res; 1997 Jul; 3(7):1045-9. PubMed ID: 9815782 [TBL] [Abstract][Full Text] [Related]
13. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Takaoka A; Hinoda Y; Satoh S; Adachi Y; Itoh F; Adachi M; Imai K Oncogene; 1998 Mar; 16(11):1443-53. PubMed ID: 9525743 [TBL] [Abstract][Full Text] [Related]
14. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma. Guo XZ; Friess H; Di Mola FF; Heinicke JM; Abou-Shady M; Graber HU; Baer HU; Zimmermann A; Korc M; Büchler MW Hepatology; 1998 Dec; 28(6):1481-8. PubMed ID: 9828210 [TBL] [Abstract][Full Text] [Related]
15. Defining regulatory elements in the human KAI1 (CD 82) metastasis suppressor gene. Gao AC; Lou W; Dong JT; Barrett JC; Danielpour D; Isaacs JT Prostate; 2003 Dec; 57(4):256-60. PubMed ID: 14601021 [TBL] [Abstract][Full Text] [Related]
16. KAI1/CD82, a tumor metastasis suppressor. Liu WM; Zhang XA Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083 [TBL] [Abstract][Full Text] [Related]
17. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Guo X; Friess H; Graber HU; Kashiwagi M; Zimmermann A; Korc M; Büchler MW Cancer Res; 1996 Nov; 56(21):4876-80. PubMed ID: 8895737 [TBL] [Abstract][Full Text] [Related]
18. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells. Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295 [TBL] [Abstract][Full Text] [Related]
19. Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes. Mashimo T; Bandyopadhyay S; Goodarzi G; Watabe M; Pai SK; Gross SC; Watabe K Biochem Biophys Res Commun; 2000 Aug; 274(2):370-6. PubMed ID: 10913345 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer. Schindl M; Birner P; Breitenecker G; Oberhuber G Gynecol Oncol; 2001 Nov; 83(2):244-8. PubMed ID: 11606078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]